The Intelligence from The Economist cover image

Clotting factors: the AstraZeneca vaccine

The Intelligence from The Economist

00:00

Intro

This chapter examines recent analysis by European and British regulators regarding the potential link between blood clots and the AstraZeneca-Oxford COVID vaccine. It discusses the implications of these findings, the cautious stance of health authorities, and the effects on public perception and vaccine rollout.

Play episode from 00:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app